Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 4/20 | 0.38 |
| ▸ | CDK2AP1 | O14519 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9996373 | 1.00 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3CYP2D6CHEK1 | |
| SCHEMBL9996371 | 1.00 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3CYP2D6CHEK1 | |
| SCHEMBL4972502 | 0.77 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL6508980 | 0.76 | KMT2A (0.48) | SLC6A4SLC6A3CHEK1CDK2AP1 | |
| SCHEMBL1862766 | 0.76 | SLC6A4 (0.48) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL3616023 | 0.76 | SLC6A4 (0.48) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL1862764 | 0.76 | SLC6A4 (0.48) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL3616019 | 0.76 | SLC6A4 (0.48) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL1862768 | 0.76 | SLC6A4 (0.48) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL1866954 | 0.76 | SLC6A4 (0.48) | SLC6A2SLC6A4SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1966139-B1 | ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS INC (US) | 2011-12-21 | — | — | EP | disclosed |